Physician profile
Ahmad Khaldi
NPI 1679736938
$5,400.61
in general payments reported to CMS, 2019-2025
21 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2020: $1,342 · 2021: $126 · 2022: $2,530 · 2023: $554 · 2024: $158 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,675.50 | 2021-2023 | Pipeline |
| Silk Road Medical, INC. | $872.85 | 2020 | |
| Stryker Corporation | $609.52 | 2019-2025 | Surpass Evolve, Target, Evolve |
| Microvention, INC. | $281.80 | 2020 | |
| Scientia Vascular | $155.12 | 2023 | |
| Portola Pharmaceuticals, LLC | $122.27 | 2019 | |
| Irras USA, INC. | $119.20 | 2023 | |
| Depuy Synthes Sales INC. | $90.37 | 2019-2020 | |
| Abbott Laboratories | $85.86 | 2020 | |
| Siemens Medical Solutions USA, INC. | $75.04 | 2021-2024 | Artis Icono Biplane |
| Ucb, INC. | $71.65 | 2019-2020 | |
| Chiesi USA, INC. | $42.36 | 2019-2020 | |
| Avanos Medical | $36.52 | 2019 | |
| Haemonetics Corporation | $36.37 | 2019 | |
| Natus Medical Incorporated | $30.12 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $29.21 | 2020 | |
| Rigel Pharmaceuticals, INC. | $17.88 | 2022 | |
| Pfizer INC. | $17.05 | 2019 | |
| Boston Scientific Corporation | $16.24 | 2022 | |
| Nuvasive, INC. | $15.68 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Khaldi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.